| Literature DB >> 26797583 |
V Machado Rolim1, R Assis Casagrande2, A Terezinha Barth Wouters3, D Driemeier4, S Petinatti Pavarini4.
Abstract
Viral infections have been implicated as the cause of cardiomyopathy in several mammalian species. This study describes hypertrophic cardiomyopathy (HCM) and myocarditis associated with feline immunodeficiency virus (FIV) infection in five cats aged between 1 and 4 years. Clinical manifestations included dyspnoea in four animals, one of which also exhibited restlessness. One animal showed only lethargy, anorexia and vomiting. Necropsy examination revealed marked cardiomegaly, marked left ventricular hypertrophy and pallor of the myocardium and epicardium in all animals. Microscopical and immunohistochemical examination showed multifocal infiltration of the myocardium with T lymphocytes and fewer macrophages, neutrophils and plasma cells. An intense immunoreaction for FIV antigen in the cytoplasm and nucleus of lymphocytes and the cytoplasm of some macrophages was observed via immunohistochemistry (IHC). IHC did not reveal the presence of antigen from feline calicivirus, coronavirus, feline leukaemia virus, feline parvovirus, Chlamydia spp. or Toxoplasma gondii. The results demonstrate the occurrence of FIV infection in inflammatory cells in the myocardium of five cats with myocarditis and HCM.Entities:
Keywords: feline immunodeficiency virus; hypertrophic cardiomyopathy; immunohistochemistry; myocarditis
Mesh:
Year: 2016 PMID: 26797583 PMCID: PMC7094316 DOI: 10.1016/j.jcpa.2015.10.180
Source DB: PubMed Journal: J Comp Pathol ISSN: 0021-9975 Impact factor: 1.311
Primary antibodies and immunohistochemical protocols applied in the study
| Antibody | Antigen retrieval | Dilution | Detection method | Chromogen |
|---|---|---|---|---|
| Mouse anti-feline immunodeficiency virus, p24 gag (AbD Serotec, Kidlington, UK) | 40 min, 100°C, 0.01 M citrate buffer pH 6.0 | 1 in 100 | LSAB-AP | PR |
| Mouse anti-feline calicivirus, FCV2-16 (Custom Monoclonals, Sacramento, California, USA) | 20 min, 37°C, P-XIV | 1 in 50 | MACH 4 | AEC |
| Mouse anti-coronavirus, FIPV3-70 (Santa Cruz Biotechnology, Dallas, Texas, USA) | 20 min, 100°C, 0.01 M citrate buffer pH 6.0 | 1 in 300 | LSAB-HRP | DAB |
| Mouse anti-feline leukaemia virus, gp 70 (AbD Serotec) | 40 min, 100°C, Tris–EDTA buffer pH 9.0 | 1 in 500 | LSAB-AP | PR |
| Mouse anti-feline/canine parvovirus (AbD Serotec) | 20 min, 37°C, P-XIV | 1 in 1,000 | LSAB-HRP | AEC |
| Mouse anti- | 5 min, 37°C P-K (ready to use) | 1 in 100 | LSAB-HRP | AEC |
| Mouse anti-CD79αcy, HN57 (Dako, Carpinteria, California, USA) | 20 min, 100°C, Tris–EDTA buffer pH 9.0 | 1 in 100 | LSAB-HRP | DAB |
| Goat anti- | 10 min, 37°C trypsin 0.1% and microwave (700 W), 2 min, 0.01 M citrate buffer, pH 6.0 | 1 in 1,000 | LSAB-HRP | DAB |
| Rabbit anti-human lysozyme, EC 3.2.1.17 (Dako) | 10 min, 37°C P-K | 1 in 200 | LSAB-HRP | DAB |
| Rabbit anti-human CD3 (Dako) | 20 min, 37°C P-XIV | 1 in 500 | LSAB-AP | PR |
P-XIV, protease XIV (Sigma); P-K, proteinase-K (Dako); LSAB-HRP, biotin–peroxidase–streptavidin (Dako); LSAB-AP, streptavidin–biotin–alkaline phosphatase (Dako); MACH 4, universal HRP-polymer (Biocare); AEC, 3-amino-9-ethylcarbazole (Dako); DAB, 3, 3′ diaminobenzidine (Dako); PR, permanent red (Dako).
Signalment, clinical presentation and gross post-mortem findings in cats of this study
| Cat number | Breed, age and sex | Clinical signs | Gross lesions (non-cardiac) | Cardiac lesions |
|---|---|---|---|---|
| 1 | Persian, 10 months, male | Dyspnoea | Lungs oedematous and heavy | Cardiomegaly, left ventricular hypertrophy, multifocal to coalescing white–tan areas in myocardium and epicardium |
| 2 | Persian, 4 years, male | Restlessness, dyspnoea | Lungs oedematous and heavy, liver enlarged and dark | Cardiomegaly, left ventricular hypertrophy, multifocal to coalescing white–tan areas in myocardium and epicardium |
| 3 | Crossbred, 3 years, female | Dyspnoea | Blue tongue and oral mucosae, moderate hydrothorax, lungs oedematous and heavy | Moderate pericardial effusion with fibrin. Irregular epicardial surface. Cardiomegaly, left ventricular hypertrophy, multifocal to coalescing white–tan areas in myocardium and epicardium |
| 4 | Crossbred, 1.5 years, male | Lethargy, anorexia, vomiting | Pale mucous membranes. Hydrothorax and ascites with fibrin. Lungs odematous and heavy | Cardiomegaly, left ventricular hypertrophy, myocardial pallor |
| 5 | Crossbred, 1 year, male | Dyspnoea | Blue oral mucosae. Cervical and thoracic vessels engorged. Moderate hydrothorax. Lungs oedematous and heavy. Liver enlarged and dark | Cardiomegaly, left ventricular hypertrophy, myocardial pallor, thrombus in right atrium |
Fig. 1Myocarditis and hypertrophic cardiomyopathy in a cat infected with FIV. There is moderate cardiomegaly with pallor of the epicardium. Small white nodules are scattered over the epicardial surface. Bar, 3 cm.
Fig. 2Myocarditis and hypertrophic cardiomyopathy in a cat infected with FIV. Cross-sections of different levels of the heart showing marked hypertrophy of the ventricular muscles, mainly in the left ventricle, with narrowing of the ventricular lumen. There is also myocardial pallor. Bar, 3 cm.
Fig. 3Histopathological change in the heart of a cat infected with FIV and presenting with myocarditis and HCM. There is marked multifocal inflammatory infiltration. HE. Bar, 350 μm.
Fig. 4Immunoreaction for FIV antigen (red colour) in the cytoplasm of lymphocytes present in the myocardium. IHC. Bar, 100 μm.
Intensity of immunohistochemical labelling for FIV, CD3, lysozyme and CD79
| Cat number | FIV | CD3 | CD79 | Lysozyme in macrophages | Lysozyme in neutrophils |
|---|---|---|---|---|---|
| 1 | ++ | ++ | − | + | ++ |
| 2 | +++ | +++ | − | + | +++ |
| 3 | ++ | ++ | − | + | + |
| 4 | + | ++ | − | + | +++ |
| 5 | +++ | +++ | − | ++ | + |
−, negative; +, mild; ++, moderate; +++, marked.